天臣医疗跌2.15%，成交额3589.25万元，主力资金净流出91.35万元

Company Overview - Tianchen Medical is located in Suzhou Industrial Park, Jiangsu Province, and was established on August 18, 2003. The company was listed on September 28, 2020. Its main business involves the research, innovation, production, and sales of high-end surgical staplers [1]. - The company operates in the pharmaceutical and biological industry, specifically in the medical devices and medical consumables sector. It is associated with concepts such as high dividends, buybacks, strong annual performance, margin financing, and specialized innovation [1]. Financial Performance - As of June 30, Tianchen Medical reported a revenue of 156 million yuan, representing a year-on-year growth of 17.66%. The net profit attributable to the parent company was 48.21 million yuan, showing a year-on-year increase of 67.10% [1]. - Since its A-share listing, Tianchen Medical has distributed a total of 171 million yuan in dividends, with 139 million yuan distributed over the past three years [2]. Stock Performance - On September 8, Tianchen Medical's stock price decreased by 2.15%, trading at 55.88 yuan per share, with a total transaction volume of 35.89 million yuan and a turnover rate of 0.78%. The company's total market capitalization is 4.535 billion yuan [1]. - Year-to-date, the stock price has increased by 236.02%. Over the last five trading days, it has decreased by 3.36%, while it has increased by 49.89% over the last 20 days and 104.91% over the last 60 days [1]. - As of the latest data, the number of shareholders is 4,148, a decrease of 6.64% from the previous period, while the average circulating shares per person increased by 7.11% to 19,564 shares [1]. Capital Flow - In terms of capital flow, there was a net outflow of 913,500 yuan from main funds, with large orders buying 3.92 million yuan (10.94% of total) and selling 4.84 million yuan (13.48% of total) [1].